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Bacteremia Increases the Risk of Death among Patients
with Soft-Tissue Infections
Scott T. Micek,1 Alex P. Hoban,1 Victor Pham,2 Joshua A. Doherty,2 Marya D. Zilberberg,3
Andrew F. Shorr,4 and Marin H. Kollef5
Abstract
Background: Soft-tissue infections traditionally have been viewed as carrying a lower risk of death than other
types of infection such as pneumonia, blood stream, and intra-abdominal. The influence of secondary bacteremia
on the outcomes of patients with soft-tissue infections is not well described.
Objectives: To describe the risk factors for bacteremia among patients admitted to an urban medical center with
soft-tissue infections and the influence of bacteremia on outcomes.
Methods: A retrospective cohort study of 717 patients with culture-positive non-necrotizing soft-tissue infections
admitted between April 1, 2005, and December 31, 2007.
Results: Bacteremia was present in 52% of the patients. Increasing age, previous hospitalization, decubitus or
lower-extremity ulcers, device-related soft-tissue infection, and polymicrobial infection were independent pre-
dictors of bacteremia. Intensive care unit admission (adjusted odds ratio [AOR] 3.57; 95% confidence interval
[CI] 2.17, 5.86), lower-extremity ulcer (AOR 3.43; 95% CI 2.07, 5.70), and bacteremia (AOR 6.37; 95% CI 3.34,
12.12) were independent predictors of in-hospital death. When patients with device-related soft-tissue infections
were excluded, the rate of secondary bacteremia was 37.6% (201=535), and it remained an independent predictor
of in-hospital death.
Conclusions: The occurrence of bacteremia in soft-tissue infections is associatedwith a greater risk of death. Health
care providers should be aware of the risk factors for bacteremia in patients with soft-tissue infections in order to
provide more appropriate initial antimicrobial therapy and to ascertain its presence as a prognostic indicator.
Soft-tissue infections are common, generally of mild tomodest severity, and easily treated with a variety of an-
timicrobial agents [1]. Bacteremia complicating soft-tissue
infections has been described infrequently [2–4], and the in-
fluence of secondary bacteremia on the outcomes of patients
with soft-tissue infections is not well described [1]. Soft-tissue
infections complicated by bacteremia may represent a sub-
group of infections requiring more aggressive antimicrobial
therapy because of differences in causative pathogens, se-
verity of illness, and outcomes. Additionally, health care-
associated infection risk factors may play a role in the
changing epidemiology of soft-tissue infections [5]. Therefore,
we performed a study with two goals. Our first goal was
to identify the risk factors for bacteremia complicating soft-
tissue infections among patients admitted to an urbanmedical
center. The second goal was to determine the influence of
bacteremia on patient outcomes.
Patients and Methods
Study design
A retrospective cohort analysis was performed of all cul-
ture-positive patients admitted to Barnes-Jewish Hospital
(a 1,200-bed urban teaching hospital) between April 1, 2005,
andDecember 31, 2007,with a diagnosis of soft-tissue infection.
Data source
Two investigators (VP, JAD) identified all study patients by
the presence of either a primary or a secondary ICD-9-CM
code indicative of soft-tissue infection and a concomitant
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positive culture from the site of infection or a positive blood
culture (see Appendix). The study database was constructed
(by APH) by merging patient-specific data from the auto-
mated hospital records and microbiology and pharmacy da-
tabases of Barnes-Jewish Hospital.
Definitions
For the purposes of this investigation, soft-tissue infections
were limited to non-necrotizing infections and included cu-
taneous abscesses, furuncles and carbuncles, cellulitis and
erysipelas, ulcers, surgical site infections, and device-related
infections (including arterial grafts, arteriovenous fistulas or
shunts, insulin infusion pumps, peripheral dialysis catheters,
and internal orthopedic implants and excluding central ve-
nous, Hickman, and peripherally inserted catheters and Port-
a-caths) as defined in the recent Infectious Diseases Society
of America guidelines [1] (see Appendix Table 1). Device-
related infections were included only if there was clinical
evidence of soft-tissue infection (e.g., cellulitis, abscess) su-
perficial to the device. Necrotizing infections, including nec-
rotizing fasciitis, clostridial myonecrosis, and pyomyositis,
were excluded, as these infections require immediate surgical
intervention (see Appendix Table 2).
Health care-associated soft-tissue infection was said to be
present in patients admitted to the hospital with a diagnosis of
soft-tissue infection who met the following criteria: (1) Ad-
mission from a nursing home, rehabilitation hospital, or other
long-term nursing care facility; (2) hospitalization within the
immediately preceding 12 months; (3) receiving outpatient
hemodialysis, peritoneal dialysis, or infusion therapy neces-
sitating regular visits to a hospital-based clinic; and (4) being
in an immunocompromised state.
The diagnosis of soft-tissue infection was verified by one of
the investigators (STM) from the medical database and re-
quired documentation of the site of infection plus at least one
of the following: (1) White blood cell count> 10,000103=mL;
(2) temperature 38.38C; or (3) purulent discharge from the
infection site. Acceptable positive culture specimens included
abscess drainage, aspirate from the leading edge of a cellulitis
lesion or involved soft tissue, surgical biopsy, non-abscess
purulent drainage, deep tissue, and purulent discharge from
an ulcer or wound. Blood cultures were accepted if the same
organism was identified in a soft-tissue culture or no other
source for the positive blood culture could be identified.
For patients with a device-related infection, confirmation of
the presence of overlying soft-tissue infection was confirmed
using the electronic medical record.
Data analysis
All comparisons were unpaired, and all tests of significance
were two-tailed. Continuous variables were compared using
the Student t-test for normally distributed variables and the
Mann-Whitney U test for non-normally distributed variables.
The chi-square or Fisher exact test was used to compare cat-
egorical variables. We performed multiple logistic regression
analysis using SPSS Version 11.0 for Windows (SPSS, Inc.,
Chicago, IL). Multivariable analysis was performed using
models judged a priori to be clinically sound. This was de-
termined prospectively to be necessary to avoid producing
spuriously significant results with multiple comparisons. All
potential risk factors significant at the 0.2 level in univariable
analyses were entered in the model.
Results
Patient characteristics
A total of 717 culture-positive patients with soft-tissue
infection were admitted to Barnes-Jewish Hospital during the
study period. One hundred nine patients (15.2%) had more
than one soft-tissue infection identified during the same
hospitalization. The mean age of the population was 51.5
17.4 years (range 14–99 years). The study included 374
(52.2%) male and 343 (47.8%) female patients. There were 372
patients (51.9%) with secondary bacteremia, and 527 patients
(73.5%) were classified as having a health care-associated
infection. The characteristics of the patients with soft-tissue
infection segregated by the presence or absence of bacteremia
and in-hospital death are provided in Table 1. Hospitaliza-
tion during the previous 12 months was the most common
criterion for classification as a health care-associated infec-
tion. Among patients with a device-related infection, 176
(96.7%) had cellulitis and an abscess overlying the device
(Table 2).
Risk factors for bacteremia
Patients with secondary bacteremia were statistically more
likely to have a health care-associated infection than were the
non-bacteremic patients (Table 1). The health care-associated
risk factors that significantly differentiated patients with bac-
teremia from thosewithout were prior hospitalization, admis-
sion from a nursing home or extended care facility, and
chronic hemodialysis. Bacteremic patients were significantly
more likely to have end-stage renal disease, neutropenia,
insulin-requiring diabetes mellitus, underlying malignant
disease, cirrhosis, or peripheral vascular disease than were
non-bacteremic patients. Bacteremic patients also were sig-
nificantly more likely to have an infection characterized by a
decubitus ulcer, lower-extremity ulcer, device-related infec-
tion, gram-negative bacteria, Candida, or polymicrobial in-
fection and less likely to have an abscess with cellulitis,
postoperative incisional infection, or gram-positive bacterial
infection (Tables 1 and 2).
Patients with bacteremia were significantly more likely
to have infection with Enterobacter spp., Escherichia coli, Kleb-
siella spp., Stenotrophomonas maltophilia, Enterococcus faecalis,
Ent. faecium, vancomycin-resistant enterococci, or coagulase-
negative staphylococci and less likely to have infection with
methicillin-resistant Staphylococcus aureus, the community-
associated phenotype of methicillin-resistant S. aureus, or
non-group A and B streptococci. Patients with soft-tissue
infections associated with bacteremia were significantly less
likely to have their culture source be an abscess, tissue aspi-
rate, purulent drainage, tissue, or drainage from an ulcer than
were non-bacteremic patients.
Excluding patients with a device-related infection resulted
in similar findings. Among the 535 such patients, there were
201 (37.6%) with secondary bacteremia. Patients with device-
related soft-tissue infections had a significantly greater inci-
dence of secondary bacteremia than did patients without
device-related infections (94.0% vs. 37.6%; p< 0.001). Among
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patients with a decubitus ulcer, 46 of 87 infections were
polymicrobial (52.9%), including 5 (5.7%) associated with
polymicrobial bacteremia.
Logistic regression analysis of the entire study cohort
identified increasing age, previous hospitalization, decubitus
or lower-extremity ulcers, device-related soft-tissue infection,
and polymicrobial infection as independent predictors of
bacteremia (Table 3). When patients with device-related soft-
tissue infections were excluded, being a nursing home resi-
dent was an independent predictor of bacteremia, whereas
abscess and cellulitis formation and surgical site infection
were associated independently with the absence of secondary
bacteremia (Table 3).
Risk factors for in-hospital death
Compared with survivors, non-survivors were signifi-
cantly older, more likely to be nursing home residents, require
intensive care unit admission, or have health care-associated
infection; underlying malignant disease; a solid organ allo-
graft; a decubitus or lower-extremity ulcer; Candida infection;
infection with Ent. faecalis, Ent. faecium, or vancomycin-
resistant enterococci; or bacteremia and less likely to have
abscess and cellulitis on a location other than a digit, gram-
positive bacteria, methicillin-resistant S. aureus, other non-
group A and B streptococci, or a causative organism isolated
from an abscess (Tables 1 and 2). Logistic regression analysis
demonstrated that intensive care unit admission, lower-ex-
tremity ulcer, and bacteremia were independently associated
with in-hospital death (Table 4). Excluding patients with a
device-related infection resulted in the same variables plus
underlyingmalignant disease being identified as independent
risk factors for in-hospital death. Kaplan-Meier curves com-
paring patients with soft-tissue infections with or without
bacteremia demonstrated a greater risk of in-hospital death
for bacteremic patients (p¼ 0.007; log-rank test) (Fig. 1). A
similar statistically significant difference in the hospital mor-
tality rates of bacteremic and non-bacteremic patients was
identified when individuals with device-related soft-tissue
infections were excluded (p< 0.001; log-rank test).
Outcomes analysis
Patients with bacteremia had a greater risk admission to an
intensive care unit and of in-hospital death (Table 5). Hospital
length of stay was statistically longer for bacteremic patients,
and they were less likely to be discharged to home and more
likely to be discharged to a nursing home or other acute care
















Mean age (years) standard
deviation
56.0 17.2 46.4 16.4 <0.001 63.2 15.5 50.8 17.4 <0.001










White 178 (47.8) 162 (47.0) 0.964 23 (62.2) 317 (46.6) 0.140
African-American 185 (49.7) 174 (50.4) 14 (37.8) 345 (50.7)
Other 9 ( 2.4) 9 ( 2.6) 0 ( 0.0) 18 ( 2.6)
Health care-associated
infection (%)
318 (85.5) 209 (60.6) <0.001 35 (94.6) 492 (72.4) 0.002
Previous hospitalization (%)
0–3 months 249 (66.9) 123 (35.7) <0.001 31 (83.8) 341 (50.1) <0.001
4–6 months 155 (41.7) 67 (19.4) <0.001 18 (48.6) 204 (30.0) 0.017
7–12 months 141 (37.9) 69 (20.0) <0.001 16 (43.2) 194 (28.5) 0.055
Antibiotics prior to
admission (%)
60 (16.1) 56 (16.2) 0.970 7 (18.9) 109 (16.0) 0.642
Nursing home resident (%) 71 (19.1) 12 ( 3.5) <0.001 13 (35.1) 70 (10.3) <0.001
Home health care (%) 2 ( 0.5) 0 ( 0.0) 0.500 0 ( 0.0) 2 ( 0.3) 1.000
Chronic hemodialysis (%) 54 (14.5) 4 ( 1.2) <0.001 3 ( 8.1) 55 ( 8.1) 1.000
Intensive care unit
admission (%)
29 ( 7.8) 13 ( 3.8) 0.022 8 (21.6) 34 ( 5.0) <0.001
Co-morbidities (%)
End-stage renal disease 63 (16.9) 8 ( 2.3) <0.001 5 (13.5) 66 ( 9.7) 0.401
Neutropenia 12 ( 3.2) 0 ( 0.0) <0.001 1 ( 2.7) 11 ( 1.6) 0.473
Human immunodeficiency
virus positive
10 ( 2.7) 11 ( 3.2) 0.825 0 ( 0.0) 21 ( 3.1) 0.619
Insulin-requiring diabetes
mellitus
128 (34.4) 83 (24.1) 0.002 15 (40.5) 196 (28.8) 0.128
Underlying malignant
disease
79 (21.2) 35 (10.1) <0.001 13 (35.1) 101 (14.9) 0.001
Solid organ transplant 9 ( 2.4) 3 ( 0.9) 0.146 4 (10.8) 8 ( 1.2) 0.002
Cirrhosis 34 ( 9.1) 18 ( 5.2) 0.043 3 ( 8.1) 49 ( 7.2) 0.745
Peripheral vascular disease 18 ( 4.8) 4 ( 1.2) 0.004 2 ( 5.4) 20 ( 2.9) 0.316
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Device-relateda 171 (46.0) 11 ( 3.2) <0.001 11 (29.7) 171 (25.1) 0.533
Abscess and cellulitis, location
other than toe
93 (25.0) 238 (69.0) <0.001 11 (29.7) 320 (47.1) 0.039
Decubitus ulcer 77 (20.7) 10 ( 2.9) <0.001 11 (29.7) 76 (11.2) 0.001
More than one soft-tissue infection
during same admission
56 (15.1) 53 (15.4) 0.908 7 (18.9) 102 (15.0) 0.518
Lower-extremity ulcer 44 (11.8) 24 ( 7.0) 0.026 8 (21.6) 60 ( 8.8) 0.010
Postoperative incision site 31 ( 8.3) 83 (24.1) <0.001 3 ( 8.1) 111 (16.3) 0.249
Chronic ulcer 8 ( 2.2) 5 ( 1.4) 0.581 1 ( 2.7) 12 ( 1.8) 0.501
Abscess and cellulitis on toe 5 ( 1.3) 19 ( 5.5) 0.003 0 ( 0.0) 24 ( 3.5) 0.629
Extremity stump 3 ( 0.8) 6 ( 1.7) 0.325 1 ( 2.7) 8 ( 1.2) 0.381
Carbuncle or furnuncle 2 ( 0.5) 1 ( 0.3) 1.000 0 ( 0.0) 3 ( 0.4) 1.000
Pilonidal cyst 0 ( 0.0) 3 ( 0.9) 0.111 0 ( 0.0) 3 ( 0.4) 1.000
Pathogen type (%)
Gram-positive bacteria 277 (74.5) 303 (87.5) <0.001 25 (67.6) 554 (81.5) 0.037
Polymicrobial 151 (40.6) 79 (22.9) <0.001 13 (35.1) 217 (31.9) 0.682
Gram-negative bacteria 142 (38.2) 67 (19.4) <0.001 16 (43.2) 193 (28.4) 0.053
Candida species 35 ( 9.4) 9 ( 2.6) <0.001 6 (16.2) 38 ( 5.6) 0.009
Specific pathogen
Pseudomonas aeruginosa 38 (10.2) 23 ( 6.7) 0.089 5 (13.5) 56 ( 8.2) 0.233
Escherichia coli 36 ( 9.7) 11 ( 3.2) <0.001 5 (13.5) 42 ( 6.2) 0.087
Klebsiella spp. 31 ( 8.3) 5 ( 1.4) <0.001 4 (10.8) 32 ( 4.7) 0.098
Enterobacter spp. 17 ( 4.6) 6 ( 1.7) 0.035 0 ( 0.0) 23 ( 3.4) 0.625
Proteus mirabilis 13 ( 3.5) 8 ( 2.3) 0.351 2 ( 5.4) 19 ( 2.8) 0.296
Acinetobacter spp. 9 ( 2.4) 3 ( 0.9) 0.146 1 ( 2.7) 11 ( 1.6) 0.473
Citrobacter spp. 8 ( 2.2) 4 ( 1.2) 0.388 0 ( 0.0) 12 ( 1.8) 1.000
Bacteroides fragilis 7 ( 1.9) 12 ( 3.5) 0.184 0 ( 0.0) 19 ( 2.8) 0.617
Serratia marcescens 6 ( 1.6) 4 ( 1.2) 0.754 0 ( 0.0) 10 ( 1.5) 1.000
Stenotrophomonas maltophilia 6 ( 1.6) 0 ( 0.0) 0.031 0 ( 0.0) 6 ( 0.9) 1.000
Morganella spp. 4 ( 1.1) 2 ( 0.6) 0.688 1 ( 2.7) 5 ( 0.7) 0.273
Methicillin-resistant Staphylococcus
aureus
99 (26.6) 153 (44.3) <0.001 7 (18.9) 245 (36.0) 0.034
Coagulase-negative staphylococci 86 (23.1) 22 ( 6.4) <0.001 8 (21.6) 100 (14.7) 0.252
Methicillin-susceptible S. aureus 67 (18.0) 66 (19.1) 0.700 6 (16.2) 127 (18.7) 0.708
Other streptococci 44 (11.8) 72 (20.9) 0.001 1 ( 2.7) 115 (16.9) 0.020
Enterococcus faecalis 44 (11.8) 7 ( 2.0) <0.001 6 (16.2) 45 ( 6.6) 0.027
Community-associated MRSA
phenotype
26 ( 7.0) 76 (22.0) <0.001 2 ( 5.4) 100 (14.7) 0.147
Vancomycin-resistant enterococci 25 ( 6.7) 3 ( 0.9) <0.001 7 (18.9) 21 ( 3.1) <0.001
Enterococcus faecium 24 ( 6.5) 3 ( 0.9) <0.001 5 (13.5) 22 ( 3.2) 0.010
Group B streptococci 14 ( 3.8) 19 ( 5.5) 0.266 0 ( 0.0) 33 ( 4.9) 0.406
Group A streptococci 4 ( 1.1) 6 ( 1.7) 0.533 0 ( 0.0) 10 ( 1.5) 1.000
Streptococcus pneumoniae 2 ( 0.5) 1 ( 0.3) 1.000 0 ( 0.0) 3 ( 0.4) 1.000
Culture source (%)
Wound 77 (20.7) 60 (17.4) 0.260 4 (10.8) 133 (19.6) 0.281
Abscess 15 ( 4.0) 228 (66.1) <0.001 2 ( 5.4) 241 (35.4) <0.001
Tissue 8 ( 2.2) 43 (12.5) <0.001 0 ( 0.0) 51 ( 7.5) 0.101
Drainage 7 ( 1.9) 48 (13.9) <0.001 0 ( 0.0) 55 ( 8.1) 0.104
Aspirate 6 ( 1.6) 26 ( 7.5) <0.001 1 ( 2.7) 31 ( 4.6) 1.000
Biopsy 2 ( 0.5) 4 ( 1.2) 0.435 1 ( 2.7) 5 ( 0.7) 0.273
Ulcer 1 ( 0.3) 7 ( 2.0) 0.032 0 ( 0.0) 8 ( 1.2) 1.000
Cyst 0 ( 0.0) 1 ( 0.3) 0.481 0 ( 0.0) 1 ( 0.1) 1.000
Blood N=A N=A N=A 34 (91.9) 338 (49.7) <0.001
aIncludes arterial grafts, arteriovenous fistulas or shunts, insulin infusion pumps, peripheral dialysis catheters, and internal orthopedic
implants.
N=A¼not available.
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facility. Similar results were observed when patients with
device-related infections were excluded (Table 5).
Discussion
We showed that bacteremia complicating soft-tissue in-
fections was common among patients admitted to an urban
medical center and was associated with excess in-hospital
deaths. Logistic regression analysis demonstrated that the
occurrence of bacteremia was independently associated with
death. We also found that certain risk factors may be associ-
ated with bacteremia in patients with soft-tissue infec-
tions: Increasing age, previous hospitalization, a decubitus
or lower-extremity ulcer, device-related infection, and
polymicrobial infection. Additionally, more than half of the
soft-tissue infections in our study were classified as health
care-associated. Our study addresses a different population
from that in other reports of soft-tissue infections [1]. We did
this purposefully to evaluate a more inclusive population
pertinent to clinicians working in the hospital setting. Patients
with bacteremia were statistically more likely to require in-
tensive care unit admission, have longer hospital stays, be
discharged to a nursing home or other acute care facility, or
die during their hospitalization than were patients without
bacteremia.
Clinical assessment of the severity of soft-tissue infections is
crucial to ensure that timely and appropriate treatment is
administered [1]. Most assessment schemes attempt to dif-
ferentiate necrotizing fromnon-necrotizing infections because
of the urgent need for surgical intervention in the former [6].
Bacteremia complicating cellulitis has been described previ-
ously but has not been shown to be associated with a greater
risk of morbidity and death [2–4]. Bacteremia complicating
cellulitis caused by non-group A streptococci superimposed
on lymphedema occurs in 30% of patients [7]. This high
prevalence of bacteremia has been attributed to the lymphe-
dema and the virulence of the infecting bacterial species [8].
Other types of cellulitis involving the buccal or periorbital
area, in patients in whom a salt-water or fresh-water source of
infection is likely, and in patients with evidence of a systemic
inflammatory response, are more likely to be associated with
bacteremia [8].
Table 3. Multivariable Analysis of Independent Risk Factors for Bacteremia
Variable Adjusted odds ratio 95% Confidence interval P value
Entire cohorta
Age (1-year increments) 1.02 1.01, 1.03 0.020
Previous hospitalization (0–3 months) 1.61 1.27, 2.01 0.031
Decubitus ulcer 9.25 6.20, 13.82 <0.001
Lower-extremity ulcer 3.00 2.17, 4.14 0.001
Device-related infectionb 25.46 17.10, 37.90 <0.001
Polymicrobial infection 1.92 1.52, 2.42 0.005
Excluding patients with device-related infectionc
Age (1-year increments) 1.02 1.01, 1.03 0.024
Previous hospitalization (0–3 months) 2.01 1.56, 2.59 0.006
Decubitus ulcer 4.35 2.78, 6.80 0.001
Lower-extremity ulcer 2.23 1.57, 3.17 0.023
Polymicrobial infection 2.54 2.01, 3.23 <0.001
Nursing home resident 3.86 2.34, 6.37 0.007
Abscess and cellulitis other location 0.37 0.28, 0.52 0.002
Postoperative surgical site infection 0.25 0.17, 0.36 <0.001
aOther covariates not in the table had a p value> 0.05, including nursing home resident, chronic hemodialysis, insulin-requiring diabetes
mellitus, neutropenia, underlying malignant disease, cirrhosis, peripheral vascular disease, abscess and cellulitis on digit, abscess and
cellulitis other location, postoperative surgical site infection, gram-negative bacteria, gram-positive bacteria, and Candida spp. (p¼ 0.419;
Hosmer-Lemeshow goodness-of-fit test).
bIncludes arterial grafts, arteriovenous fistulas or shunts, insulin infusion pumps, peripheral dialysis catheters, and internal orthopedic
implants.
cOther covariates not in the table had a p value> 0.05, including chronic hemodialysis, insulin-requiring diabetes mellitus, neutropenia,
underlying malignant disease, cirrhosis, abscess and cellulitis on digit, and gram-positive bacteria (p¼ 0.282; Hosmer-Lemeshow goodness-
of-fit test).
Table 4. Multivariable Analysis of Independent Risk Factors for In-Hospital Deatha
Variable Adjusted odds ratio 95% Confidence interval P value
Intensive care unit admission 3.57 2.17, 5.86 0.010
Lower-extremity ulcer 3.43 2.07, 5.70 0.015
Bacteremia 6.37 3.34, 12.12 0.004
aOther covariates not in the table had a p value> 0.05, including age, race, health care-associated infection, previous hospitalization (0–3
months), nursing home resident, insulin-requiring diabetes mellitus, underlying malignant disease, solid-organ transplant, abscess and
cellulitis other location, decubitus ulcer, gram-negative bacterial infection, gram-positive bacterial infection, and Candida spp. infection
(p¼ 0.787; Hosmer-Lemeshow goodness-of-fit test).
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Peralta et al. reviewed the records of patients with limb
cellulitis in a teaching hospital to identify predictors of bac-
teremia [9]. Among 308 patients (among 2,678 patients pre-
senting to the hospital with cellulitis) having blood culture, 57
(18.5%) had bacteremia. Risk factors for bacteremia included
absence of previous antimicrobial treatment, presence of two
or more co-morbid conditions, length of illness less than two
days, and proximal limb involvement. In an accompanying
editorial, Eron and Lipsky suggested that clinicians should
employ such risk factors to assist in determining when blood
cultures should be obtained for patients with cellulitis [10].
Unfortunately, similar studies identifying risk factors for
bacteremia in other types of soft-tissue infections are lacking.
Jahamy et al. recently demonstrated that bacteremia accom-
panying S. aureus soft-tissue infectionswas similar for Panton-
Valentine leukocidin (PVL)-positive and -negative isolates
[11]. Predictors of bacteremia in their study included age 65
years or greater, necrotizing infection, and head=neck location
of the infection.
Our study examined a consecutive group of patients ad-
mitted to a large referral hospital with a variety of soft-tissue
infections. Other experiences examining soft-tissue infections
differ from our study in that they examined specific types of
bacteria, geographic locations, or infection types. Sebeny et al.
described soft-tissue infections caused bymulti-drug resistant
Acinetobacter baumannii among soldiers with war wounds
[12]. This illustrates the importance of recognizing specific
risk factors for infection with highly virulent or resistant
pathogens in order to administer appropriate antimicrobial
therapy in a timely manner. Similarly, Chang et al. demon-
strated that community-onset skin and soft-tissue infections
in Taiwan caused by Klebsiella pneumoniaewere more likely to
be associated with bacteremia and shock than those attribut-
able to other bacteria [13]. Those investigators recommended
that in their geographic area, clinicians be aware of this
finding in order to initiate broader antimicrobial therapy in
patients having skin and soft-tissue infections complicated by
shock. Other authors have highlighted the need to recognize
that soft-tissue infections associated with foreign bodies can
be difficult to treat and often necessitate removal of the for-
eign body or more protracted antibiotic therapy for success
[14,15].
Several important limitations of our investigation should
be noted. First, we evaluated only culture-positive infections.
Therefore, we may have missed patients with soft-tissue in-
fections who had negative cultures because of either early
antibiotic administration or inadequate specimens submitted
for microbiologic evaluation. Second, our study was per-
formed at a single hospital with demonstrated high rates of
health care-associated infections among patients admitted
with culture-positive infections [16]. As a result, our findings
may not be applicable to hospitals with a lower proportion of
patients having health care-associated risk factors at admis-
sion. Third, we included patients with device-related soft-
tissue infections. This appeared to be an important risk factor
for bacteremia and may represent a distinct type of soft-tissue
infection similar to catheter-associated bacteremia. The lack of
a separate classification for device-related soft-tissue infec-
tions is a limitation that needs to be addressed, especially
because this type of infection accounted for more than 25% of
our population. Fourth, we did not employ a severity of ill-
ness score. It is possible that patients dying with bacteremia
may have been sicker than non-bacteremic patients. The re-
sults of ourmultivariable analysis refute this idea, however, in
showing that a marker of greater disease severity (require-
ment for intensive care unit admission) was independently
FIG. 1. Impact of bacteremia on mortality rate.
Table 5. Outcomes


















In-hospital death (%) 34 ( 9.1) 3 ( 0.9) <0.001 24 (11.9) 2 (0.6) <0.001
Intensive care unit admission (%) 29 ( 7.8) 13 ( 3.8) 0.022 18 ( 9.0) 12 (3.6) 0.009
Mean hospital stay standard
deviation (days)
11.0 16.1 5.5 6.8 <0.001 10.1 9.8 5.1 5.9 <0.001
Disposition (%)
Home 186 (50.0) 241 (69.9) <0.001 90 (44.8) 237 (71.0) <0.001
Home health care 81 (21.8) 79 (22.9) 0.718 36 (17.9) 75 (22.5) 0.209
Home hospice 6 ( 1.6) 1 ( 0.3) 0.125 4 ( 2.0) 1 ( 0.3) 0.069
Nursing home 49 (13.2) 15 ( 4.3) <0.001 32 (15.9) 13 (13.9) <0.001
Other acute care facility 16 ( 4.3) 6 ( 1.7) 0.047 15 ( 7.5) 6 ( 1.8) 0.001
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associated with death along with bacteremia complicating
soft-tissue infections. Lastly, because of the retrospective na-
ture of our study, we may have missed identifying other
important factors associated with bacteremia and in-hospital
death.
In summary, we found that bacteremia complicating soft-
tissue infections is common and associated with a greater risk
of death. Clinicians should consider obtaining blood cultures
in patients with soft-tissue infections who have risk factors
predisposing to this complication. The identification of path-
ogens in blood cultures offers prognostic information and
may help in directing antimicrobial therapy for patients with
soft-tissue infections.
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Appendix
TABLE 1. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Codes
for Complicated Skin and Skin-Structure Infections included in Analysis
Principal diagnosis code Description
680 Carbuncle and furuncle
681 Cellulitis and abscess of finger and toe
682 Other cellulitis and abscess
683 Acute lymphadenitis
685 Pilonidal cyst with abscess
686 Other local infections of skin and subcutaneous tissue
707 Decubitus ulcer
707.1 Ulcers of lower limbs, except decubitus ulcers
707.8 Chronic ulcer of other specified sites
707.9 Chronic ulcer of unspecified site
958.3 Post-traumatic wound infection, not elsewhere classified
996.62 Infection due to other vascular device, implant, or graft
997.62 Infection (chronic) of amputation stump
998.5 Postoperative wound infection
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